ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
WinHealth and Immedica enter agreement giving Winhealth rights to Ravicti? in China and several other Asia-Pacific countries prnasia
December 31, 2020Hongkong WinHealth Pharma Group CO., Ltd and Immedica Pharma AB, today announce that they have entered an agreement under which WinHealth gains the exclusive commercial rights to Ravicti? (glycerol phenylbutyrate), in a territory covering the ... -
Horizon Pharma Announces FDA Approval to Expand Age Range for RAVICTI
americanpharmaceuticalreview
December 29, 2018Horizon Pharma announced the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) to expand the age range for....
Pharma Sources Insight January 2025
